Phaseline

Targets › HEV

HEV: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Infectious disease.

Open in Phaseline: the race on HEV, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
International Vaccine InstituteHecolin® Recombinant Hepatitis E Vaccine
Recombinant hepatitis E virus (HEV) vaccine
HEVPhase 2Hepatitis E Virus Infection–

Conditions

Hepatitis E Virus Infection (1)

Modalities

mixed (1)

Companies

International Vaccine Institute (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.